// App-Quantinova.ai

: Quantifying AD-related brain amyloid with linearised progression models: model-based vs. data-based.

Researchers

Presenter

  • Alle Meije Wink

Principal Investigators

  • Mahnaz Shekari

  • Ellen Dicks

  • Lyduine E. Collij

  • Gemma Salvadó

  • David Vállez García

  • Juan Domingo Gispert

  • Betty M. Tijms

  • Isadora Lopes Alves

  • Maqsood Yaqub

  • Frederik Barkhof

Medical Centers

  • Department of Anatomy and Neurosciences, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC

  • Clinical Memory Research Unit, Lund University

  • On behalf of the AMYPAD consortium

  • Amsterdam University Medical Center

  • Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC

  • Mayo Clinc

  • Institutes of Neurology & Healthcare Engineering, University College London

  • Department of Anatomy and Neurosciences, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC

  • Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation

  • Amsterdam UMC, location VUmc

Locations

  • United States

  • United Kingdom

  • Venezuela

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Mild cognitive impairment

Biomarkers

  • N/A

Drug/Treatment

  • 18F-florbetapir

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved